Suppression-Associated Immune Programs in Triple-Negative Breast Cancer Beyond Effector Enrichment: A Multi-Cohort Transcriptomic Analysis
International Journal of Molecular Sciences · 14.11.2026 · 27 (22) · 10208
DOI: 10.3390/ijms272210208 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.11.2026. Verfasst von Shorog Al Omair und 1 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Faisal University.
Abstract (Originalsprache)
High immune-cell infiltration does not guarantee effective anti-tumor immunity. Suppression of anti-tumor immunity may explain the variable prognosis and immunotherapy response of immune-inflamed triple-negative breast cancer (TNBC). We asked whether suppression-associated transcriptional signals merely accompanied effector-rich infiltration or retained a distinct association with TNBC across cohorts. Across TCGA-BRCA (discovery, n = 728), METABRIC (replication, n = 1980), and a Saudi exploratory cohort (n = 38), we evaluated a predefined effector immunity composite, an immunoregulatory cell-enrichment composite, and a six-gene suppressive myeloid-associated transcriptional score (CSF3R, OLR1, C5AR1, CLEC4E, ARG2, S100A8). In TCGA-BRCA, the effector immunity composite and six-gene score were both elevated and co-varied strongly (Spearman ρ = 0.66). Notably, the six-gene score remained associated with TNBC after adjustment for effector enrichment and age. The immunoregulatory cell-enrichment composite showed no significant difference, with opposing shifts among its components. In METABRIC, the main findings replicated and all three programs were elevated; the Saudi cohort showed concordant elevation. In a post hoc joint model with all three programs and age, the six-gene score remained positively associated with TNBC in TCGA-BRCA (OR 2.37) and METABRIC (OR 1.27). The six-gene score thus captured reproducible TNBC-associated variation beyond effector enrichment. Our findings motivate investigating whether this myeloid–effector interplay relates to TNBC prognosis and therapy response.
Förderung
- King Faisal University
Zitieren
APA
Omair, S. A., & Almsned, F. (2026). Suppression-Associated Immune Programs in Triple-Negative Breast Cancer Beyond Effector Enrichment: A Multi-Cohort Transcriptomic Analysis. International Journal of Molecular Sciences, 27(22), 10208. https://doi.org/10.3390/ijms272210208
Vancouver
Omair SA, Almsned F. Suppression-Associated Immune Programs in Triple-Negative Breast Cancer Beyond Effector Enrichment: A Multi-Cohort Transcriptomic Analysis. International Journal of Molecular Sciences. 2026;27(22):10208. doi:10.3390/ijms272210208
BibTeX
@article{Omair2026,
author = {Omair, Shorog Al and Almsned, Fahad},
title = {Suppression-Associated Immune Programs in Triple-Negative Breast Cancer Beyond Effector Enrichment: A Multi-Cohort Transcriptomic Analysis},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {22},
pages = {10208},
doi = {10.3390/ijms272210208}
}
EUVIMED